Recent studies have centered on the overlap of GLP-1|GIP|GCGR stimulant therapies and DA neurotransmission. While GLP activators are commonly employed for managing type 2 T2DM, their emerging impacts on motivation https://katrinaqsdt024674.frewwebs.com/40321639/emerging-gcgr-activators-and-dopaminergic-adjustment-a-comparative-overview